Related Experiment Videos
Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it?
Yolanda Braun-Moscovici1, Daniel E Furst
1UCLA Medical School, Rheumatology Division, Los Angeles, California 98101, USA.
Current Opinion in Rheumatology
|April 23, 2003
There is no simple answer to the question: intravenous immunoglobulin-take it or leave it? A thorough review of the current data on mechanisms of action, efficacy, and safety of intravenous immunoglobulins in rheumatic diseases demonstrates that the answer depends on the disease and the patients involved.
There is no simple answer to the question: intravenous immunoglobulin-take it or leave it? A thorough review of the current data on mechanisms of action, efficacy, and safety of intravenous immunoglobulins in rheumatic diseases demonstrates that the answer depends on the disease and the patients involved.